By Karen Roman NanoCell Therapeutics, Inc. said it published data in the Journal for ImmunoTherapy of Cancer showing the ...

Circulating tumor cells (CTCs) refer to cancer cells that have broken off from a primary tumor. These tumor cells can travel ...

Hematopoietic stem cells (HSCs) are the fundamental building blocks of our circulatory system, giving rise to all blood cell ...

Discover how cutting-edge tools and analytics are advancing cell therapy, improving precision, safety and scalability in ...

New RNA vaccine shows promise in turning resistant tumors into immunotherapy targets. Study offers hope for more effective, ...

The therapeutic impact of glycine was evaluated in various HBV-infected cell lines and murine models via various methodologies including transcriptomic sequencing, metabolomics sequencing, flow ...

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells.

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells. The approach ...

We report phase I trial results for pasritamig, a first-in-class, T-cell–engaging bispecific antibody targeting human kallikrein 2 (KLK2) expressed on the surface of prostate cancer (PC) cells.

Cytek Biosciences launches the Aurora™ Evo, an advanced flow cytometer enhancing throughput and automation for cell analysis.

TCR T-cell therapies represent a breakthrough in solid tumor treatment by targeting intracellular antigens presented by human leukocyte antigen molecules, expanding potential treatment applications ...